Bismerthiazol
| Code | Size | Price |
|---|
| CDX-B0246-G001 | 1 g | £159.00 |
Quantity:
| CDX-B0246-G010 | 10 g | £978.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
Ambient
Storage:
+4 °C
Documents
Further Information
Appearance:
White to off-white solid.
CAS:
79319-85-0
EClass:
32160000
Form (Short):
liquid
Handling Advice:
Protect from light and moisture.
InChi:
InChI=1S/C5H6N6S4/c12-4-10-8-2(14-4)6-1-7-3-9-11-5(13)15-3/h1H2,(H,6,8)(H,7,9)(H,10,12)(H,11,13)
InChiKey:
RSNWORHVUOZYLT-UHFFFAOYSA-N
Long Description:
Chemical. CAS: 79319-85-0. Formula: C5H6N6S4. MW: 278.4. Synthetic. Reference standard.
MDL:
MFCD01681864
Molecular Formula:
C5H6N6S4
Molecular Weight:
278.4
Package Type:
Vial
Product Description:
Reference standard.
Purity:
>98% (HPLC)
SMILES:
S=C1NN=C(NCNC2=NNC(=S)S2)S1
Solubility Chemicals:
Soluble in chloroform.
Source / Host:
Synthetic.
Transportation:
Non-hazardous
UNSPSC Category:
Biochemical Reagents
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at +4°C.
Related Products
| Product Name | Product Code | Supplier | Azimsulfuron | CDX-A0203 | Chemodex | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Benthiavalicarb-isopropyl | CDX-B0243 | Chemodex | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Spinosad | CDX-S0044 | Chemodex | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Vindoline | CDX-V0002 | Chemodex | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||